Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group …

T Kümpfel, K Giglhuber, O Aktas, I Ayzenberg… - Journal of …, 2024 - Springer
This manuscript presents practical recommendations for managing acute attacks and
implementing preventive immunotherapies for neuromyelitis optica spectrum disorders …

[HTML][HTML] Role of Selenium in Pathogenesis and Treatment of the Autoimmune Diseases

E Rahmani, AM Fard, H Baghsheikhi, Z Hosseini… - Kindle, 2022 - preferpub.org
In vitro investigations have revealed that consumption of selenium can considerably
decrease the expression of IFN-g in Th1 cells. A low plasma selenium content has been …

[HTML][HTML] A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein …

MI Leite, Z Panahloo, N Harrison, J Palace - Multiple Sclerosis and Related …, 2023 - Elsevier
Background Aquaporin-4 antibody positive (AQP4+) neuromyelitis optica spectrum disorder
(NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) …

[HTML][HTML] Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review

P Siriratnam, S Huda, H Butzkueven… - Autoimmunity …, 2023 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a rare central nervous system
autoimmune disease. Aquaporin-4 antibody (AQP4-IgG) is present in over 75% of cases and …

[HTML][HTML] Disease-modifying treatments for neuromyelitis optica spectrum disorder in the context of a new generation of biotherapies

S Demuth, N Collongues - Revue Neurologique, 2024 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a rare but debilitating autoimmune
disease of the central nervous system (CNS) for which several biotherapies have recently …

Monoclonal antibody therapies for aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody …

N Tisavipat, HY Juan, JJ Chen - Saudi Journal of Ophthalmology, 2023 - journals.lww.com
Monoclonal antibody therapies mark the new era of targeted treatment for relapse
prevention in aquaporin-4 (AQP4)-immunoglobulin G (IgG)-positive neuromyelitis optica …

[HTML][HTML] 妊娠期原发性干燥综合征合并视神经脊髓炎谱系疾病危重症1 例

吴洁, 张雯, 梁舒, 秦艺璐, 范文强 - Journal of Peking University …, 2023 - ncbi.nlm.nih.gov
原发性干燥综合征(primary Sjögren's syndrome, pSS) 的中枢神经系统受累少见,
常表现为脑白质病变、 视神经脊髓炎谱系疾病(neuromyelitis optica spectrum disorder …

[PDF][PDF] Epidural Anesthesia for Neuromyelitis Optica in Obstetrics: A Case Report and Literature Review

AT Grigoriadou, T Asimakopoulos, C Orfanou… - Cureus, 2024 - cureus.com
Neuromyelitis optica (NMO), also known as Devic disease, poses unique challenges in
obstetrical anesthesia, with limited research available. This case report presents the …

[PDF][PDF] Mohsen Motavaselian

P Mazaheri, R Roohinezhad, SSR Ramsheh, A Shafigh… - researchgate.net
Neuronal injury, leading to characteristic multifocal plaques apparent on magnetic
resonance imaging and a wide variety of neurologic symptoms. The disease pathology is …